Tag Archives: Forest Laboratories

Doing More With Less: A Leadership Perspective

By Jennifer Ringler | Published: July 19, 2011
Steven Blum, Director of Health Economics at Forest Laboratories and one of Pharm Exec’s 2011 Emerging Pharma leaders, recently spoke with Associate Editor Jennifer Ringler on building leadership and team rapport in today’s lean organization.
Posted in Agency Insight, Corporate Responsibility, leadership | Also tagged , , , , | 2 Comments

Inspector General Puts Forest CEO in the Crosshairs

By Ben Comer | Published: April 15, 2011
Forest Laboratories’ CEO Howard Solomon was no doubt surprised to receive a form letter from the Office of Inspector General (OIG) on April 8, which, if acted upon, would exclude him from doing business with federal healthcare plans, including Medicare and Medicaid. Solomon has 30 days to explain to the OIG why he should not be [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

Feds End Use of Seven Inhalers (But Not All At Once)

By George Koroneos | Published: April 14, 2010
Image by noii’s via Flickr FDA, on Tuesday, announced that it would phase out the use of seven asthma and chronic obstructive pulmonary disease inhalers to keep in check with regulations banning devices containing chlorofluorocarbons (CFCs). Four of the devices have already been discontinued, and the manufacturers of the remaining devices will have to find suitable replacements [...]
Posted in Regulatory, Strategy | Also tagged , , , , , , | Leave a comment